BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 27571790)

  • 1. Mucinous and Signet Ring Cell Differentiation Affect Patterns of Metastasis in Colorectal Carcinoma and Influence Survival.
    Kermanshahi TR; Magge D; Choudry H; Ramalingam L; Zhu B; Pingpank J; Ahrendt S; Holtzman M; Zeh H; Bartlett D; Zureikat A; Pai RK
    Int J Surg Pathol; 2017 Apr; 25(2):108-117. PubMed ID: 27571790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
    Kakar S; Deng G; Smyrk TC; Cun L; Sahai V; Kim YS
    Mod Pathol; 2012 Jul; 25(7):1040-7. PubMed ID: 22522845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma.
    Sung CO; Seo JW; Kim KM; Do IG; Kim SW; Park CK
    Mod Pathol; 2008 Dec; 21(12):1533-41. PubMed ID: 18849918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
    Hartman DJ; Binion DG; Regueiro MD; Miller C; Herbst C; Pai RK
    Inflamm Bowel Dis; 2018 Jul; 24(8):1780-1790. PubMed ID: 29788391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
    Benedix F; Kuester D; Meyer F; Lippert H
    Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of CT manifestations of primary colorectal mucinous adenocarcinoma and signet ring cell carcinoma].
    Li Z; Zhang Z; Dong X; Gao D; Zhang D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):315-319. PubMed ID: 28338167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
    Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
    Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signet ring cell differentiation in mucinous colorectal carcinoma.
    Börger ME; Gosens MJ; Jeuken JW; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
    J Pathol; 2007 Jul; 212(3):278-86. PubMed ID: 17471475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis.
    Hartman DJ; Nikiforova MN; Chang DT; Chu E; Bahary N; Brand RE; Zureikat AH; Zeh HJ; Choudry H; Pai RK
    Am J Surg Pathol; 2013 Jul; 37(7):969-77. PubMed ID: 23681075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of signet-ring cells in patients with colorectal cancer.
    Pande R; Sunga A; Levea C; Wilding GE; Bshara W; Reid M; Fakih MG
    Dis Colon Rectum; 2008 Jan; 51(1):50-5. PubMed ID: 18030531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
    Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
    Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.
    Tung SY; Wu CS; Chen PC
    Am J Gastroenterol; 1996 Oct; 91(10):2195-9. PubMed ID: 8855747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
    Ogino S; Brahmandam M; Cantor M; Namgyal C; Kawasaki T; Kirkner G; Meyerhardt JA; Loda M; Fuchs CS
    Mod Pathol; 2006 Jan; 19(1):59-68. PubMed ID: 16118624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.
    Secco GB; Fardelli R; Campora E; Lapertosa G; Gentile R; Zoli S; Prior C
    Oncology; 1994; 51(1):30-4. PubMed ID: 8265100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort.
    Nitsche U; Friess H; Agha A; Angele M; Eckel R; Heitland W; Jauch KW; Krenz D; Nüssler NC; Rau HG; Ruppert R; Schubert-Fritschle G; Wilhelm D; Werner J; Engel J
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2357-66. PubMed ID: 27573386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas.
    Kubota K; Akasu T; Fujita S; Sugihara K; Moriya Y; Yamamoto S
    Hepatogastroenterology; 2004; 51(55):142-6. PubMed ID: 15011850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression.
    Lam AK; Ong K; Ho YH
    Dis Colon Rectum; 2006 Sep; 49(9):1275-83. PubMed ID: 16912910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.